INS and type 2 diabetes mellitus: A multinational randomized trial compared the efficacy and safety of insulin degludec/insulin aspart (IDegAsp) with biphasic insulin aspart 30 (BIAsp 30) in patients with T2DM who fasted during Ramadan.